191 related articles for article (PubMed ID: 2712415)
1. In vitro immune monitoring of antibody response in dogs given chemoimmunotherapy for lymphoma.
Jeglum KA; Winters WD; Young KM
Am J Vet Res; 1989 Apr; 50(4):488-92. PubMed ID: 2712415
[TBL] [Abstract][Full Text] [Related]
2. Intralymphatic autochthonous tumor cell vaccine in canine lymphoma.
Jeglum KA; Young KM; Barnsley K; Whereat A; McGrath D; Hutson C
J Biol Response Mod; 1986 Apr; 5(2):168-75. PubMed ID: 3734843
[TBL] [Abstract][Full Text] [Related]
3. Chemotherapy versus chemotherapy with intralymphatic tumor cell vaccine in canine lymphoma.
Jeglum KA; Young KM; Barnsley K; Whereat A
Cancer; 1988 May; 61(10):2042-50. PubMed ID: 3359402
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of a multidrug chemotherapy protocol with mitoxantrone based maintenance (CHOP-MA) for the treatment of canine lymphoma.
Daters AT; Mauldin GE; Mauldin GN; Brodsky EM; Post GS
Vet Comp Oncol; 2010 Mar; 8(1):11-22. PubMed ID: 20230577
[TBL] [Abstract][Full Text] [Related]
5. Comparison of the effects of asparaginase administered subcutaneously versus intramuscularly for treatment of multicentric lymphoma in dogs receiving doxorubicin.
Valerius KD; Ogilvie GK; Fettman MJ; Walton JA; Richardson K; Powers BE; McNiel EA; Rogers QR
J Am Vet Med Assoc; 1999 Feb; 214(3):353-6. PubMed ID: 10023395
[TBL] [Abstract][Full Text] [Related]
6. Doxorubicin alone or in combination with asparaginase, followed by cyclophosphamide, vincristine, and prednisone for treatment of multicentric lymphoma in dogs: 121 cases (1987-1995).
Valerius KD; Ogilvie GK; Mallinckrodt CH; Getzy DM
J Am Vet Med Assoc; 1997 Feb; 210(4):512-6. PubMed ID: 9040837
[TBL] [Abstract][Full Text] [Related]
7. Autologous marrow transplantation as consolidation therapy for canine lymphoma: efficacy and toxicity of various regimens of total body irradiation.
Deeg HJ; Appelbaum FR; Weiden PL; Hackman RC; Graham TC; Storb RC
Am J Vet Res; 1985 Sep; 46(9):2016-8. PubMed ID: 3901841
[TBL] [Abstract][Full Text] [Related]
8. Treatment of canine lymphoma with COPLA/LVP.
Boyce KL; Kitchell BE
J Am Anim Hosp Assoc; 2000; 36(5):395-403. PubMed ID: 10997514
[TBL] [Abstract][Full Text] [Related]
9. Thirteen-week dose-intensifying simultaneous combination chemotherapy protocol for malignant lymphoma in dogs.
Zenker I; Meichner K; Steinle K; Kessler M; Hirschberger J
Vet Rec; 2010 Nov; 167(19):744-8. PubMed ID: 21257510
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of some prognostic factors for advanced multicentric lymphosarcoma in the dog: 147 cases (1978-1981).
MacEwen EG; Hayes AA; Matus RE; Kurzman I
J Am Vet Med Assoc; 1987 Mar; 190(5):564-8. PubMed ID: 3558097
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of factors associated with second remission in dogs with lymphoma undergoing retreatment with a cyclophosphamide, doxorubicin, vincristine, and prednisone chemotherapy protocol: 95 cases (2000-2007).
Flory AB; Rassnick KM; Erb HN; Garrett LD; Northrup NC; Selting KA; Phillips BS; Locke JE; Chretin JD
J Am Vet Med Assoc; 2011 Feb; 238(4):501-6. PubMed ID: 21320021
[TBL] [Abstract][Full Text] [Related]
12. Results of chemotherapy for cats with alimentary malignant lymphoma: 21 cases (1993-1997).
Zwahlen CH; Lucroy MD; Kraegel SA; Madewell BR
J Am Vet Med Assoc; 1998 Oct; 213(8):1144-9. PubMed ID: 9787382
[TBL] [Abstract][Full Text] [Related]
13. Efficacy of a continuous, multiagent chemotherapeutic protocol versus a short-term single-agent protocol in dogs with lymphoma.
Simon D; Moreno SN; Hirschberger J; Moritz A; Kohn B; Neumann S; Jurina K; Scharvogel S; Schwedes C; Reinacher M; Beyerbach M; Nolte I
J Am Vet Med Assoc; 2008 Mar; 232(6):879-85. PubMed ID: 18341445
[TBL] [Abstract][Full Text] [Related]
14. A combination chemotherapy protocol (VELCAP-L) for dogs with lymphoma.
Zemann BI; Moore AS; Rand WM; Mason G; Ruslander DM; Frimberger AE; Wood CA; L'Heureux DA; Gliatto J; Cotter SM
J Vet Intern Med; 1998; 12(6):465-70. PubMed ID: 9857340
[TBL] [Abstract][Full Text] [Related]
15. Natural killer cell activity in untreated and treated dogs with lymphoma.
Raskin RE; Tvedten HW; Bull RW; Crow SE; Dunstan RW; Krehbiel JD
Am J Vet Res; 1989 Apr; 50(4):483-7. PubMed ID: 2712414
[TBL] [Abstract][Full Text] [Related]
16. What is your diagnosis? Ocular lymphoma.
Cave T; Billson M
J Small Anim Pract; 2003 Dec; 44(12):523, 553-4. PubMed ID: 14692547
[No Abstract] [Full Text] [Related]
17. Evaluation of a discontinuous treatment protocol (VELCAP-S) for canine lymphoma.
Moore AS; Cotter SM; Rand WM; Wood CA; Williams LE; London CA; Frimberger AE; L'Heureux DA
J Vet Intern Med; 2001; 15(4):348-54. PubMed ID: 11467592
[TBL] [Abstract][Full Text] [Related]
18. Histologic classification as an indication of therapeutic response in malignant lymphoma of dogs.
Gray KN; Raulston GL; Gleiser CA; Jardine JH
J Am Vet Med Assoc; 1984 Apr; 184(7):814-7. PubMed ID: 6725115
[TBL] [Abstract][Full Text] [Related]
19. Chemoimmunotherapy for canine lymphosarcoma: a prospective evaluation of specific and nonspecific immunomodulation.
Weller RE; Theilen GH; Madewell BR; Crow SE; Benjamini E; Villalobos A
Am J Vet Res; 1980 Apr; 41(4):516-21. PubMed ID: 6893260
[TBL] [Abstract][Full Text] [Related]
20. Phase II clinical trial of combination chemotherapy with dexamethasone for lymphoma in dogs.
Greenberg CB; Boria PA; Borgatti-Jeffreys A; Raskin RE; Lucroy MD
J Am Anim Hosp Assoc; 2007; 43(1):27-32. PubMed ID: 17209082
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]